• Long-Term Study of Vosoritide Safety and Effectiveness in Children with Hypochondroplasia Until Adult Height is Reached

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy Spain
  • Testing trifluridine, tipiracil and nanoliposomal irinotecan combination for patients with bile duct or gallbladder cancer after previous treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Germany
  • Testing dehydroepiandrosterone combined with standard antidepressants for patients with treatment-resistant depression

    Recruiting

    3 1 1
    Investigated Diseases:
    Germany
  • Study of lidocaine to reduce opioid use in patients with sickle cell disease experiencing severe pain crisis

    Recruiting

    3 1 1
    France
  • Study of fianlimab plus cemiplimab with chemotherapy or cemiplimab with chemotherapy for patients with pleural mesothelioma who have not received prior treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • A study to test how well empagliflozin works and how safe it is for children and teenagers with chronic kidney disease

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Hungary Italy The Netherlands +4
  • A Study of Belzutifan and Zanzalintinib Compared to Cabozantinib in Patients with Advanced Kidney Cancer that Returned After Previous Treatment

    Recruiting

    3 1 1 1
    Austria Belgium Croatia Czechia Denmark France +6
  • Testing the Safety and Effects of TUB-030 in Patients with Advanced Head and Neck Cancer or Non-Small-Cell Lung Cancer

    Recruiting

    2 1 1
    Investigated Drugs:
    France Romania Spain
  • A study testing the reduction of heart failure drug combination in patients with heart failure in remission

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium
  • A Study Comparing DZD8586 to Other Treatments for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Has Returned or Not Responded

    Recruiting

    3 1 1 1
    Italy Poland

powered by